Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 13, 2025 • 12:11 PM ET

Date/Time Source News Release
05/13/2025 04:05 PM EDT PR Newswire INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights
04/30/2025 08:05 AM EDT PR Newswire INOVIO to Present at Upcoming Scientific and Investor Conferences
04/29/2025 08:05 AM EDT PR Newswire INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025
04/09/2025 08:05 AM EDT PR Newswire INOVIO to Present at Upcoming Scientific Conferences
03/18/2025 04:05 PM EDT PR Newswire INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
03/13/2025 06:15 PM EDT PR Newswire INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19
03/12/2025 12:55 PM EDT PR Newswire INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025
02/12/2025 08:00 AM EST PR Newswire Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications
02/10/2025 08:05 AM EST PR Newswire Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference
01/29/2025 04:14 PM EST PR Newswire INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Page

Additional News

As of June 13, 2025 • 12:11 PM ET

Date/Time Source News Release
05/28/2025 09:35 AM EDT SeekingAlpha Crispr Therapeutics, Clover Health among healthcare stocks to join Russell 3000; INO, SAVA to exit
05/13/2025 07:06 PM EDT SeekingAlpha Inovio outlines BLA submission timeline for INO-3107 and reports $68.4M cash position while advancing DNA medicine pipeline
05/13/2025 07:05 PM EDT SeekingAlpha Inovio Pharmaceuticals, Inc. (INO) Q1 2025 Earnings Call Transcript
05/13/2025 05:40 PM EDT Zacks Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue Estimates
05/13/2025 04:23 PM EDT SeekingAlpha Earnings Snapshot: INOVIO says current cash pile enough to support ops till Q1 2026
05/13/2025 04:07 PM EDT SeekingAlpha Inovio Pharmaceuticals GAAP EPS of -$0.51 beats by $0.23
05/13/2025 10:00 AM EDT SeekingAlpha Here are the major earnings after the close today
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:30 AM EDT US Earnings Reports Expected earnings - Inovio Pharmaceuticals Inc.
05/12/2025 06:48 PM EDT KlickAnalytics INO - Historical Price Movements Surrounding Earnings
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.